Set2 homologs, including NSD1, NSD2, NSD3, and SETD2, are frequently mutated, translocated, or amplified in a variety of human cancers [51,52], and oncohistone mutations that dysregulate H3K36 methylation cause pediatric brain tumors [67]. Here, SETD2 is linked to cancer.